Etoricoxib

Uncommon card · No. 185137

Etoricoxib, sold under brand names including Arcoxia, Exinef and Nucoxia is a selective COX-2 inhibitor developed and commercialized by Merck. It is approved in 63 countries worldwide as of 2007, except the United States where the Food and Drug Administration sent a Non Approvable Letter to Merck and required them to provide additional data. It was patented in 1996 and approved for medical use in 2002.

Read on Wikipedia · Image Fvasconcellos, Public domain